Cargando…
N-Octyl Caffeamide, a Caffeic Acid Amide Derivative, Prevents Progression of Diabetes and Hepatic Steatosis in High-Fat Diet Induced Obese Mice
The underlying pathological mechanisms of diabetes are complicated and varied in diabetic patients, which may lead to the current medications often failing to maintain glycemic control in the long term. Thus, the discovery of diverse new compounds for developing medicines to treat diabetes and its c...
Autores principales: | Wu, Miao-Yi, Liu, Chia-Chu, Lee, Su-Chu, Kuo, Yueh-Hsiung, Hsieh, Tusty-Jiuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409300/ https://www.ncbi.nlm.nih.gov/pubmed/36012215 http://dx.doi.org/10.3390/ijms23168948 |
Ejemplares similares
-
Caffeic Acid Phenethyl Ester and Caffeamide Derivatives Suppress Oral Squamous Cell Carcinoma Cells
por: Shih, Yin-Hwa, et al.
Publicado: (2023) -
In Vitro and In Vivo Studies on Protective Action of N-Phenethyl Caffeamide against Photodamage of Skin
por: Kuo, Yueh-Hsiung, et al.
Publicado: (2015) -
N-(4-methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms
por: Kuo, Yueh-Hsiung, et al.
Publicado: (2017) -
Caffeic Acid Phenylethyl Amide Protects against the Metabolic Consequences in Diabetes Mellitus Induced by Diet and Streptozocin
por: Weng, Yi-Chun, et al.
Publicado: (2012) -
In Vitro Antimicrobial Potential of CAPE and Caffeamide Derivatives against Oral Microbes
por: Shih, Yin-Hwa, et al.
Publicado: (2022)